Antiveral kombinationsbehandling er også blevet associeret med metaboliske abnormiteter som hypertriglycerid,, hyperkolerolæmi, insulinresistens, hyperglyceridæmi og hyperlactatæmi (se afsnit 4. 4.).
Combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4).